Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 45,000
- Estimated value
- $238,050
- Report date
- 23 Sep 2024
- Price
- $5.29
- Ownership
- Direct
Barbara Klencke - Director at TScan Therapeutics, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TCRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Barbara Klencke since 05 Sep 2025
Reported holdings for Barbara Klencke in TScan Therapeutics, Inc.
Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Voting Common Stock
- Shares / value
- 25,000
- Estimated value
- $132,250
- Report date
- 23 Sep 2024
- Price
- $5.29
- Ownership
- By Trust
Form 4 holding
Director
TScan Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 67,000
- Estimated value
- Report date
- 20 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Voting Common Stock
- Underlying amount
Transaction history for Barbara Klencke in TScan Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.